Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferronyl is a trademarked form of carbonyl iron used in dietary iron supplements, valued for its high bioavailability, good tolerability, and low toxicity profile compared to other iron forms. It provides elemental iron (typically 9-54 mg per serving depending on the product) in timed-release tablet formulations that release over 6 hours to minimize gastrointestinal side effects. Iron from Ferronyl supports essential physiological functions including hemoglobin and myoglobin production for oxygen transport, cytochrome-mediated electron transport, and enzyme reactions critical for energy production, hormone synthesis, and neurological health. It is primarily indicated to treat or prevent iron deficiency, anemia, and low iron levels, particularly in contexts like pregnancy or general mineral deficiency, which is the world's most common nutrient shortfall leading to fatigue, poor concentration, and weakened immunity.[1][2][3][5][8]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ferronyl.